seasonal and pandemic influenza VLP vaccine

The **seasonal and pandemic influenza VLP vaccine** is a virus-like particle (VLP)-based vaccine platform designed to elicit immune responses against both seasonal and pandemic influenza strains. VLPs mimic the structure of influenza viruses but lack genetic material, enabling safe presentation of multiple viral antigens such as hemagglutinin (HA) from H1N1, H3N2, and influenza B strains for seasonal protection, as well as pandemic targets like H5N1. Developed using recombinant protein technology, typically in insect cells via baculovirus expression, it offers advantages in rapid strain adaptation, high yield, and broad immunogenicity without adjuvants or eggs, positioning it for flexible pandemic preparedness.